Zurück geht es hier Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.
27.06.2025 22:17:14

EQS-Adhoc: KWS SAAT SE & Co. KGaA: KWS divests stakes in North American joint ventures (AgReliant Genetics) and enters into licensing agreements

EQS-Ad-hoc: KWS SAAT SE & Co. KGaA / Key word(s): Disposal
KWS SAAT SE & Co. KGaA: KWS divests stakes in North American joint ventures (AgReliant Genetics) and enters into licensing agreements

27-Jun-2025 / 22:17 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.


KWS SAAT SE & Co. KGaA (ISIN DE0007074007) Einbeck, June 27, 2025 – KWS SAAT SE & Co. KGaA ("KWS") has today entered into an agreement to sell its 50% stakes in the North American joint ventures AGRELIANT GENETICS INC. (Canada) and AGRELIANT GENETICS LLC. (USA), collectively "AgReliant", to GDM based in Buenos Aires, Argentina ("GDM"). Through licensing agreements, KWS also sells the rights to corn breeding material from joint breeding with its joint venture partner (Limagrain Group) as well as rights to selected European corn breeding material of the KWS Group for use in North America (collectively "Transaction").

Upon completion of the transaction, the KWS Group would divest all its operational business activities in North America in the corn sector, thereby continuing the strategic alignment of its product portfolio towards long-term profitable growth and entrepreneurial independence. In the future, KWS will primarily focus on the profitable European corn business.

The Transaction volume for the sale of KWS' shares in AgReliant is in the low three-digit million range (USD) and for the licensing agreements in the mid double-digit million range (USD). The agreements provide for purchase price payments in several installments over five years, with a significant portion of the purchase price due immediately. Further details of the Transaction and the exact amounts of the purchase prices remain confidential.

The sale of KWS' shares in AgReliant will initially result in an impairment of the corresponding carrying amount in the expected low double-digit million (EUR) range in the KWS Group's financial result for the current fiscal year 2024/2025. Upon the effective date of the licensing agreements at the closing of the Transaction, KWS expects a significantly positive one-time gain in the aforementioned magnitude in the operating result of the KWS Group for the fiscal year 2025/2026 (beginning July 1, 2025). The annual forecasts of the KWS Group for the current fiscal year remain unchanged and are not affected by the Transaction.

The Transaction is subject to customary regulatory approvals and closing conditions and is expected to close during the third quarter of 2025.

AgReliant was founded in 2000 by Limagrain and KWS. AgReliant specializes in the research, production, and sale of seeds, offering high-performance corn and soybean varieties in North America.

GDM is a global group dedicated to the research, development, and commercialization of intellectual property products in plant genetics for row crops. GDM operates in 15 countries and has a team of about 3,400 employees.

Notifying person:

Peter Vogt
Head of Investor Relations
Tel. +49-30 816914490
investor.relations@kws.com
KWS SAAT SE & Co. KGaA
www.kws.com


 


End of Inside Information

27-Jun-2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: KWS SAAT SE & Co. KGaA
Grimsehlstraße 31
37555 Einbeck
Germany
Phone: +49 (0)5561 311-0
Fax: +49 (0)5561 311-322
E-mail: info@kws.com
Internet: www.kws.de
ISIN: DE0007074007
WKN: 707400
Indices: S-DAX
Listed: Regulated Market in Frankfurt (Prime Standard), Hanover; Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 2162056

 
End of Announcement EQS News Service

2162056  27-Jun-2025 CET/CEST

Analysen zu KWS SAAT SE & Co. KGaA

  • Alle
  • Kaufen
  • Hold
  • Verkaufen
  • ?
20.05.25 KWS SAAT Buy Warburg Research
16.05.25 KWS SAAT Kaufen DZ BANK
13.05.25 KWS SAAT Buy Baader Bank
13.05.25 KWS SAAT Buy Warburg Research
13.05.25 KWS SAAT Buy Jefferies & Company Inc.
Eintrag hinzufügen

Erfolgreich hinzugefügt!. Zu Portfolio/Watchlist wechseln.

Es ist ein Fehler aufgetreten!

Kein Portfolio vorhanden. Bitte zusätzlich den Namen des neuen Portfolios angeben. Keine Watchlisten vorhanden. Bitte zusätzlich den Namen der neuen Watchlist angeben.

CHF
Hinzufügen

3 Knaller-Aktien 📈im BX Musterportfolio: Dollarama, Microsoft & Intercontinental Exchang emit François Bloch

Im BX Morningcall werden folgende Aktien analysiert und erklärt:
✅ Dollarama
✅ Microsoft
✅ Intercontinental Exchange

Pünktlich zum Börsenstart diskutieren Investment-Stratege François Bloch und Börsen-Experte David Kunz oder Olivia Hähnel über ausgewählte Top-Aktienwerte aus dem BX Musterportfolio.

👉🏽 https://bxplus.ch/bx-musterportfolio/

3 Knaller-Aktien 📈im BX Musterportfolio: Dollarama, Microsoft & Intercontinental Exchange mit François Bloch

Mini-Futures auf SMI

Typ Stop-Loss Hebel Symbol
Short 12’426.44 19.92 BXPSBU
Short 12’678.44 13.98 BANSGU
Short 13’166.55 8.92 BDKS2U
SMI-Kurs: 11’980.38 27.06.2025 17:31:15
Long 11’454.22 19.60 BXGS2U
Long 11’208.93 13.98 BEFSQU
Long 10’715.67 8.89 BCHSCU
Die Produktdokumentation, d.h. der Prospekt und das Basisinformationsblatt (BIB), sowie Informationen zu Chancen und Risiken, finden Sie unter: https://keyinvest-ch.ubs.com

finanzen.net News

Datum Titel
{{ARTIKEL.NEWS.HEAD.DATUM | date : "HH:mm" }}
{{ARTIKEL.NEWS.BODY.TITEL}}